Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interaction

被引:56
|
作者
Cardoso, Rosa [1 ]
Love, Robert [1 ]
Nilsson, Carol L. [1 ]
Bergqvist, Simon [2 ]
Nowlin, Dawn [2 ]
Yan, Jiangli [1 ]
Liu, Kevin K. -C. [1 ]
Zhu, Jing [3 ]
Chen, Ping [1 ]
Deng, Ya-Li [1 ]
Dyson, H. Jane [3 ]
Greig, Michael J. [1 ]
Brooun, Alexei [1 ]
机构
[1] Pfizer Inc, Oncol Chem, Worldwide Res & Dev, San Diego, CA 92121 USA
[2] Pfizer Inc, Oncol Res Unit, Worldwide Res & Dev, San Diego, CA 92121 USA
[3] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
关键词
protein-protein interaction (PPI); crystal structure; covalent inhibitor; NMR spectroscopy; mass spectrometry; AlphaScreen; surface plasmon resonance (SPR); isothermal titration calorimetry (ITC); HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; LIGAND-BINDING; CDDO-ME; KINASE; HIF-1; HETERODIMERIZATION; DISCOVERY; RECEPTOR;
D O I
10.1002/pro.2172
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heterodimer HIF-1a (hypoxia inducible factor)/HIF-beta (also known as ARNT-aryl hydrocarbon nuclear translocator) is a key mediator of cellular response to hypoxia. The interaction between these monomer units can be modified by the action of small molecules in the binding interface between their C-terminal heterodimerization (PasB) domains. Taking advantage of the presence of several cysteine residues located in the allosteric cavity of HIF-1a PasB domain, we applied a cysteine-based reactomics hotspot identification strategy to locate regions of HIF-1a PasB domain critical for its interaction with ARNT. COMPOUND 5 was identified using a mass spectrometry-based primary screening strategy and was shown to react specifically with Cys255 of the HIF-1a PasB domain. Biophysical characterization of the interaction between PasB domains of HIF-1a and ARNT revealed that covalent binding of COMPOUND 5 to Cys255 reduced binding affinity between HIF-1a and ARNT PasB domains approximately 10-fold. Detailed NMR structural analysis of HIF-1a-PasB-COMPOUND 5 conjugate showed significant local conformation changes in the HIF-1a associated with key residues involved in the HIF-1a/ARNT PasB domain interaction as revealed by the crystal structure of the HIF-1a/ARNT PasB heterodimer. Our screening strategy could be applied to other targets to identify pockets surrounding reactive cysteines suitable for development of small molecule modulators of protein function.
引用
收藏
页码:1885 / 1896
页数:12
相关论文
共 50 条
  • [1] Next Generation SICLOPPS Screening for the Identification of Inhibitors of the HIF-1α/HIF-1β Protein-Protein Interaction
    McDermott, Alexander
    Windeln, Leonie M.
    Valentine, Jacob S. D.
    Baldassarre, Leonardo
    Foster, Andrew D.
    Tavassoli, Ali
    ACS CHEMICAL BIOLOGY, 2024, 19 (10) : 2232 - 2239
  • [2] Design, synthesis and biological evaluation of potential inhibitors of the HIF-1 \#945;:HIF-1\#946; protein-protein interaction
    Bendiabdellah, Yassine
    Zinzalla, Giovanna
    Badarch, Uranchimeg
    Nahar, Kazi
    Antonow, Dyeison
    Rahman, Khondaker
    Shoemaker, Robert
    Melillo, Giovanni
    Thurston, David
    CANCER RESEARCH, 2009, 69
  • [3] Interaction between AhR and HIF-1 signaling pathways mediated by ARNT/HIF-1β
    Zhang, Mengdi
    Hu, Yuxia
    Yang, Fan
    Zhang, Jingwen
    Zhang, Jianxin
    Yu, Wanjia
    Wang, Minjie
    Lv, Xiaoli
    Li, Jun
    Bai, Tuya
    Chang, Fuhou
    BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
  • [4] Interaction between AhR and HIF-1 signaling pathways mediated by ARNT/HIF-1β
    Mengdi Zhang
    Yuxia Hu
    Fan Yang
    Jingwen Zhang
    Jianxin Zhang
    Wanjia Yu
    Minjie Wang
    Xiaoli Lv
    Jun Li
    Tuya Bai
    Fuhou Chang
    BMC Pharmacology and Toxicology, 23
  • [5] Targeting the PAS-A domain of HIF-1α for development of small molecule inhibitors of HIF-1
    Park, Eun Jung
    Kong, Dehe
    Fisher, Robert
    Cardellina, John
    Shoemaker, Robert H.
    Melillo, Giovanni
    CELL CYCLE, 2006, 5 (16) : 1847 - 1853
  • [6] Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
    Yang, Chao
    Wang, Wanhe
    Li, Guo-Dong
    Zhong, Hai-Jing
    Dong, Zhen-Zhen
    Wong, Chun-Yuen
    Kwong, Daniel W. J.
    Ma, Dik-Lung
    Leung, Chung-Hang
    SCIENTIFIC REPORTS, 2017, 7
  • [7] Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
    Chao Yang
    Wanhe Wang
    Guo-Dong Li
    Hai-Jing Zhong
    Zhen-Zhen Dong
    Chun-Yuen Wong
    Daniel W. J. Kwong
    Dik-Lung Ma
    Chung-Hang Leung
    Scientific Reports, 7
  • [8] Small-Molecule Proteomimetic Inhibitors of the HIF-1α-p300 Protein-Protein Interaction
    Burslem, George M.
    Kyle, Hannah F.
    Breeze, Alexander L.
    Edwards, Thomas A.
    Nelson, Adam
    Warriner, Stuart L.
    Wilson, Andrew J.
    CHEMBIOCHEM, 2014, 15 (08) : 1083 - 1087
  • [9] Molecular Imaging Into In Vivo Interaction of HIF-1α and HIF-2α with ARNT
    Konietzny, Rebecca
    Koenig, Anna
    Wotzlaw, Christoph
    Bernadini, Andre
    Berchner-Pfannschmidt, Utta
    Fandrey, Joachim
    HYPOXIA AND CONSEQUENCES FROM MOLECULE TO MALADY, 2009, 1177 : 74 - 81
  • [10] FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
    Mahon, PC
    Hirota, K
    Semenza, GL
    GENES & DEVELOPMENT, 2001, 15 (20) : 2675 - 2686